Supplementary Protection Certificate rules interpreted in different ways have left the EU’s generic and biosimilar industries hungry for clarity, explains Jiri Slavik of Adalvo. If you don't have a ...

Patent cliff: 5 blockbusters running out of road ...

With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster ...

Leading patent litigator who worked on disputes involving Broadcom, Sonos, and Tesla joins firm’s Düsseldorf office from EIP. Already registered?

19 October 2023 Luxemboug court agrees with European Commission that ‘beneficial arrangement’ between Teva and Cephalon ...

11 March 2025 The ex-Cadwell Clonts Reeder & Thomas trial attorney and litigator represents clients in all phases of ...

Both parties write to district court hours after Court of Appeals denies rehearing | MSN maintains that the Entresto patent ...

To request a FREE 2-week trial subscription, please signup. NOTE - this can take up to 48hrs to be approved.

New hope for 10x’ preliminary injunction after EPO Opposition Division ruling | Patent at issue concerns single-cell spatial ...

As IP professionals wait for agency cutbacks to be felt down the chain, the advice is to stay informed, manage budgets wisely, and use a mix of protections to weather any disruption, finds Marisa ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.

The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun ...